ALLMedicine™ Type 1 Diabetes Center
Research & Reviews 34,337 results
https://doi.org/10.1007/s00125-020-05378-z 10.1007/s00125-019-4942-x 10.1016/S0140-6736(16)30507-4 10.1002/dmrr.695 10.1007/s00125-015-3562-3 10.1126/science.aat8657 10.1146/annurev-immunol-051116-052331 10.1038/nri3921 10.1172/JCI86892 10.1038/ni.3558 10.1038/ng1845 10.1056/NEJMoa1312625 10.2337/db17-0517 10.2337/db13-1777 10.1038/nm.3042 10.2337/db13-1210 10.4049/jimmunol.1601999 10.1038/s41467-017-00573-w 10.1084/jem.20161674 10.1084/jem.20182192 10.1016/j.immuni.2020.06.009 10.1016/j.fob.2014.11.009 10.1084/jem.186.10.1663 10.1371/journal.pone.0040357 10.1172/jci.insight.86065 10.21769/BioProtoc.1840 10.1074/jbc.M112.382986 10.2337/db13-1775 10.2337/db16-0616 10.1007/s00125-016-4067-4 10.1172/JCI2899 10.4049/jimmunol.1302100 10.1073/pnas.0932778100 10.1038/nri3850 10.1073/pnas.1001337107 10.1038/ng.468 10.1038/ng2091 10.1038/91070 10.1038/ng.975 10.1172/JCI78001 10.1038/ng1800 10.2337/db14-1223 10.4049/jimmunol.1300547 10.2337/db18-0331 10.1038/nature12862 10.1073/pnas.1420217112 10.1111/imm.13122 10.4049/jimmunol.1701405 10.1038/s41576-019-0151-1 10.1016/j.celrep.2018.11.047
Diabetologia Akazawa S, Mackin L et. al.
Jan 23rd, 2021 - Stimulator of IFN genes (STING) is a central hub for cytosolic nucleic acid sensing and its activation results in upregulation of type I IFN production in innate immune cells. A type I IFN gene signature seen before the onset of type 1 diabetes ha...
https://doi.org/10.1007/s00125-020-05375-2 10.1007/s00125-005-1833-0 10.1016/S2213-8587(18)30303-6 10.1136/bmjgh-2019-001410 10.1016/S2213-8587(15)00521-5 10.2337/dc17-2123 10.1001/jama.2014.6316 10.1186/s40545-016-0072-8 10.1016/S2213-8587(15)00364-2 10.1016/j.ecl.2012.03.002 10.1056/NEJMms1411398 10.1111/dme.14080 10.1046/j.1464-5491.2003.01076.x 10.1111/jphp.12852 10.1002/adma.201902004 10.1111/dme.13947 10.1016/j.tibtech.2018.07.009 10.1136/bmjgh-2018-000850 10.1016/S2213-8587(17)30218-8 10.1016/S2213-8587(19)30111-1 10.1080/16549716.2019.1670014 10.1007/s40258-016-0300-z 10.1001/jama.2016.0126 10.1016/j.diabres.2010.03.029 10.2217/dmt.10.5 10.1057/s41271-018-00159-w 10.1136/bmjgh-2019-001705 10.1177/1010539511412177 10.1002/dmrr.277 10.1001/jama.2017.6939 10.1136/bmjopen-2019-031010 10.31128/AJGP-08-19-5041 10.1111/dme.13099 10.1016/S0140-6736(06)69704-3 10.1111/j.1464-5491.2010.03053.x 10.1111/dom.12260 10.1056/NEJMp1909402 10.1016/S1751-9918(10)60004-6 10.4239/wjd.v11.i8.358 10.1111/dme.12997 10.1136/bmjgh-2020-002820 10.1016/S2213-8587(17)30181-X 10.1016/j.diabres.2019.107859 10.1093/heapol/czz043 10.7189/jogh.07.020301
Diabetologia Beran D, Lazo-Porras M et. al.
Jan 23rd, 2021 - The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A century later, availability and affordability of insulin remain a challenge in many parts of the globe. Using the WHO's framework on understanding the life c...
https://doi.org/10.1111/imcb.12437
Immunology and Cell Biology; Wiedeman AE, Speake C et. al.
Jan 23rd, 2021 - Immune monitoring enables a better understanding of disease processes and response to therapy, but has been challenging in the setting of chronic autoimmunity due to unknown etiology, variable and protracted kinetics of the disease process, hetero...
https://doi.org/10.1111/imcb.12439
Immunology and Cell Biology; Rodriguez-Fernandez S, Almenara-Fuentes L et. al.
Jan 23rd, 2021 - Type 1 diabetes (T1D) is a chronic metabolic disease caused by the autoimmune destruction of insulin-producing β-cells. Ever since the 1920s, the fate of patients suffering from T1D was dramatically improved owing to the isolation and production o...
https://doi.org/10.1111/imcb.12438
Immunology and Cell Biology; Shapiro MR, Thirawatananond P et. al.
Jan 23rd, 2021 - The conceptual basis for a genetic predisposition underlying risk for type 1 diabetes (T1D) development predates modern human molecular genetics. Over half of genetic risk has been attributed to the human leukocyte antigen (HLA) class II gene regi...
Guidelines 167 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438223
Diabetes Research and Clinical Practice; d'Annunzio G, Maffeis C et. al.
Aug 22nd, 2020 - Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.
Aug 10th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...
https://doi.org/10.1213/ANE.0000000000004491
Anesthesia and Analgesia; Martin LD, Hoagland MA et. al.
Nov 6th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.
Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al
May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...
Drugs 683 results see all →
Clinicaltrials.gov 36,877 results
https://doi.org/10.1007/s00125-020-05378-z 10.1007/s00125-019-4942-x 10.1016/S0140-6736(16)30507-4 10.1002/dmrr.695 10.1007/s00125-015-3562-3 10.1126/science.aat8657 10.1146/annurev-immunol-051116-052331 10.1038/nri3921 10.1172/JCI86892 10.1038/ni.3558 10.1038/ng1845 10.1056/NEJMoa1312625 10.2337/db17-0517 10.2337/db13-1777 10.1038/nm.3042 10.2337/db13-1210 10.4049/jimmunol.1601999 10.1038/s41467-017-00573-w 10.1084/jem.20161674 10.1084/jem.20182192 10.1016/j.immuni.2020.06.009 10.1016/j.fob.2014.11.009 10.1084/jem.186.10.1663 10.1371/journal.pone.0040357 10.1172/jci.insight.86065 10.21769/BioProtoc.1840 10.1074/jbc.M112.382986 10.2337/db13-1775 10.2337/db16-0616 10.1007/s00125-016-4067-4 10.1172/JCI2899 10.4049/jimmunol.1302100 10.1073/pnas.0932778100 10.1038/nri3850 10.1073/pnas.1001337107 10.1038/ng.468 10.1038/ng2091 10.1038/91070 10.1038/ng.975 10.1172/JCI78001 10.1038/ng1800 10.2337/db14-1223 10.4049/jimmunol.1300547 10.2337/db18-0331 10.1038/nature12862 10.1073/pnas.1420217112 10.1111/imm.13122 10.4049/jimmunol.1701405 10.1038/s41576-019-0151-1 10.1016/j.celrep.2018.11.047
Diabetologia Akazawa S, Mackin L et. al.
Jan 23rd, 2021 - Stimulator of IFN genes (STING) is a central hub for cytosolic nucleic acid sensing and its activation results in upregulation of type I IFN production in innate immune cells. A type I IFN gene signature seen before the onset of type 1 diabetes ha...
https://doi.org/10.1007/s00125-020-05375-2 10.1007/s00125-005-1833-0 10.1016/S2213-8587(18)30303-6 10.1136/bmjgh-2019-001410 10.1016/S2213-8587(15)00521-5 10.2337/dc17-2123 10.1001/jama.2014.6316 10.1186/s40545-016-0072-8 10.1016/S2213-8587(15)00364-2 10.1016/j.ecl.2012.03.002 10.1056/NEJMms1411398 10.1111/dme.14080 10.1046/j.1464-5491.2003.01076.x 10.1111/jphp.12852 10.1002/adma.201902004 10.1111/dme.13947 10.1016/j.tibtech.2018.07.009 10.1136/bmjgh-2018-000850 10.1016/S2213-8587(17)30218-8 10.1016/S2213-8587(19)30111-1 10.1080/16549716.2019.1670014 10.1007/s40258-016-0300-z 10.1001/jama.2016.0126 10.1016/j.diabres.2010.03.029 10.2217/dmt.10.5 10.1057/s41271-018-00159-w 10.1136/bmjgh-2019-001705 10.1177/1010539511412177 10.1002/dmrr.277 10.1001/jama.2017.6939 10.1136/bmjopen-2019-031010 10.31128/AJGP-08-19-5041 10.1111/dme.13099 10.1016/S0140-6736(06)69704-3 10.1111/j.1464-5491.2010.03053.x 10.1111/dom.12260 10.1056/NEJMp1909402 10.1016/S1751-9918(10)60004-6 10.4239/wjd.v11.i8.358 10.1111/dme.12997 10.1136/bmjgh-2020-002820 10.1016/S2213-8587(17)30181-X 10.1016/j.diabres.2019.107859 10.1093/heapol/czz043 10.7189/jogh.07.020301
Diabetologia Beran D, Lazo-Porras M et. al.
Jan 23rd, 2021 - The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A century later, availability and affordability of insulin remain a challenge in many parts of the globe. Using the WHO's framework on understanding the life c...
https://doi.org/10.1111/imcb.12437
Immunology and Cell Biology; Wiedeman AE, Speake C et. al.
Jan 23rd, 2021 - Immune monitoring enables a better understanding of disease processes and response to therapy, but has been challenging in the setting of chronic autoimmunity due to unknown etiology, variable and protracted kinetics of the disease process, hetero...
https://doi.org/10.1111/imcb.12439
Immunology and Cell Biology; Rodriguez-Fernandez S, Almenara-Fuentes L et. al.
Jan 23rd, 2021 - Type 1 diabetes (T1D) is a chronic metabolic disease caused by the autoimmune destruction of insulin-producing β-cells. Ever since the 1920s, the fate of patients suffering from T1D was dramatically improved owing to the isolation and production o...
https://doi.org/10.1111/imcb.12438
Immunology and Cell Biology; Shapiro MR, Thirawatananond P et. al.
Jan 23rd, 2021 - The conceptual basis for a genetic predisposition underlying risk for type 1 diabetes (T1D) development predates modern human molecular genetics. Over half of genetic risk has been attributed to the human leukocyte antigen (HLA) class II gene regi...
News 2,401 results
https://www.medscape.com/viewarticle/944111
Jan 13th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The American Diabetes Association (ADA), along with 18 other organizations, has sent a letter to the US Centers for Disease Control and Prevention...
https://www.medscape.com/viewarticle/943797
Jan 7th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Among people with type 1 diabetes (T1D) who contract COVID-19, Black individuals are four times more likely than Whites to be hospitalized with di...
https://www.medscape.com/viewarticle/943130
Dec 22nd, 2020 - A new initiative launched by the diabetes charity JDRF aims to broaden screening for type 1 diabetes risk for the general population of the United States. Called T1Detect, the program involves ordering a home fingerstick blood test for type 1 diab...
https://www.medscape.com/viewarticle/942544
Dec 13th, 2020 - (Reuters Health) - Children with type 1 diabetes who initiate insulin pump use within six months of diagnosis have better outcomes than those who delay initiation until the second or third year after diagnosis, a recent study suggests. Researchers...
https://www.medscape.com/viewarticle/942188
Dec 7th, 2020 - The risk for increased COVID-19 severity in people with type 1 diabetes appears similar to that of type 2 diabetes, contrary to some official advice from the Centers for Disease Control and Prevention (CDC). The new finding indicates that people w...
